(813) 971-8080

7210 Wareham Drive, Tampa, FL 33647

diet drugs

Weight Watchers Reports Q1 Results

May 6, 2025 WW management reported first quarter 2025 results today. “We are making progress on our strategic priorities with continued momentum in our Clinical business, while laying the foundation for long-term, sustainable growth,” said Tara Comonte, President and CEO. “As the weight management landscape evolves, we believe our unique combination of science-backed behavioral support, […]

Weight Watchers Reports Q1 Results Read More »

National Consumers League Launches “The Weight Truth,” to Combat GLP-1 Drugs Disinformation

May 1, 2025 The National Consumers League (NCL) – a leading non-profit fighting fraud in the marketplace – today released a white paper as a blueprint for policy changes to combat the flood of false information circulating online about GLP-1 products and launched an ambitious national anti-disinformation effort called the Weight Truth with the online

National Consumers League Launches “The Weight Truth,” to Combat GLP-1 Drugs Disinformation Read More »

Weight Watchers Streamlines Member Access to Zepbound® Vials

April 29, 2025 WW announced a pharmacy integration with Eli Lilly and Company’s LillyDirect® pharmacy provider, Gifthealth.  The integration will streamline access to Lilly’s FDA-approved Zepbound® (tirzepatide) single-dose vials for WeightWatchers Clinic members with an on-label prescription from their clinician. As part of WeightWatchers’ holistic approach to weight management, the integration will streamline access to

Weight Watchers Streamlines Member Access to Zepbound® Vials Read More »

Medifast Reports First Quarter Results – Slide Continues

April 28, 2025 According to CEO Dan Chard: “This year, we are focused on revitalizing our coach and customer base by supporting them with enhanced tools, data, and new products. Our business focus remains on reestablishing sustainable long-term growth while improving profitability.” First quarter 2025 revenue decreased 33.8% to $115.7 million from $174.7 million for the

Medifast Reports First Quarter Results – Slide Continues Read More »

FDA Says No More Compounded Weight Loss Drugs – Industry OFA Appeal Shot Down

March 14, 2025 On Mar. 5, a judge denied a request from the Outsourcing Facilities Association (OFA), an industry group for compounding pharmacies, to block the FDA’s attempt to stop the production of compounded tirzepatide. Generally, making copies of brand-name drugs is not legal until their patents expire. But there are exceptions: Compounding pharmacies can

FDA Says No More Compounded Weight Loss Drugs – Industry OFA Appeal Shot Down Read More »

Recession Is Coming – But Commercial Diet Companies Could Benefit

March 13, 2025 Marketdata, the parent company of DietBusinessWatch.com, has updated its report on the Commercial & Retail Weight Loss Market. Several things have become apparent as we do the research Marketdata analysts see a possible opportunity this year for the commercial (non-medical) weight loss firms to recover some ground. Here’s how we think 2025

Recession Is Coming – But Commercial Diet Companies Could Benefit Read More »

Scroll to Top